MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - pharmaceuticals
- SUVEN LIFE SCIENCES - TEVA PHARMA (Israel)
SUVEN LIFE SCIENCES vs TEVA PHARMA (Israel) - Comparison Results
TEVA PHARMA (Israel)
Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
Financials
 SUVEN LIFE SCIENCES  TEVA PHARMA |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| SUVEN LIFE SCIENCES Mar-19 |
TEVA PHARMA Dec-13 |
SUVEN LIFE SCIENCES/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 338 | 3,123 | - | |
| Low | Rs | 169 | 2,713 | - | |
| Sales per share (Unadj.) | Rs | 52.1 | 1,792.3 | - | |
| Earnings per share (Unadj.) | Rs | 6.8 | 112.0 | - | |
| Cash flow per share (Unadj.) | Rs | 8.6 | 256.8 | - | |
| Dividends per share (Unadj.) | Rs | 1.50 | 98.01 | - | |
| Dividend yield (eoy) | % | 0.6 | 3.4 | 17.6% | |
| Book value per share (Unadj.) | Rs | 65.3 | 1,990.9 | - | |
| Shares outstanding (eoy) | m | 127.28 | 848.00 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 4.9 | 1.6 | 298.8% | |
| Avg P/E ratio | x | 37.1 | 26.1 | 142.4% | |
| P/CF ratio (eoy) | x | 29.6 | 11.4 | 260.4% | |
| Price / Book Value ratio | x | 3.9 | 1.5 | 265.0% | |
| Dividend payout | % | 22.0 | 87.5 | 25.1% | |
| Avg Mkt Cap | Rs m | 32,272 | 2,474,447 | 1.3% | |
| No. of employees | `000 | 1.1 | 44.9 | 2.4% | |
| Total wages/salary | Rs m | 661 | 0 | - | |
| Avg. sales/employee | Rs Th | 6,132.2 | 33,816.7 | 18.1% | |
| Avg. wages/employee | Rs Th | 611.1 | 0 | - | |
| Avg. net profit/employee | Rs Th | 803.5 | 2,112.5 | 38.0% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 6,635 | 1,519,893 | 0.4% | |
| Other income | Rs m | 242 | 0 | - | |
| Total revenues | Rs m | 6,877 | 1,519,893 | 0.5% | |
| Gross profit | Rs m | 1,604 | 416,224 | 0.4% | |
| Depreciation | Rs m | 221 | 122,854 | 0.2% | |
| Interest | Rs m | 38 | 29,853 | 0.1% | |
| Profit before tax | Rs m | 1,587 | 263,516 | 0.6% | |
| Minority Interest | Rs m | 0 | 1,197 | 0.0% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | -172,984 | 0.0% | |
| Tax | Rs m | 718 | -3,217 | -22.3% | |
| Profit after tax | Rs m | 869 | 94,947 | 0.9% | |
| Gross profit margin | % | 24.2 | 27.4 | 88.3% | |
| Effective tax rate | % | 45.2 | -1.2 | -3,704.7% | |
| Net profit margin | % | 13.1 | 6.2 | 209.8% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 6,232 | 1,026,530 | 0.6% | |
| Current liabilities | Rs m | 1,490 | 895,221 | 0.2% | |
| Net working cap to sales | % | 71.5 | 8.6 | 827.3% | |
| Current ratio | x | 4.2 | 1.1 | 364.7% | |
| Inventory Days | Days | 86 | 91 | 95.2% | |
| Debtors Days | Days | 83 | 96 | 86.1% | |
| Net fixed assets | Rs m | 4,043 | 496,431 | 0.8% | |
| Share capital | Rs m | 127 | 3,741 | 3.4% | |
| Net worth | Rs m | 8,310 | 1,688,313 | 0.5% | |
| Long term debt | Rs m | 18 | 777,155 | 0.0% | |
| Total assets | Rs m | 10,389 | 3,473,444 | 0.3% | |
| Interest coverage | x | 43.1 | 9.8 | 438.6% | |
| Debt to equity ratio | x | 0 | 0.5 | 0.5% | |
| Sales to assets ratio | x | 0.6 | 0.4 | 146.0% | |
| Return on assets | % | 8.7 | 3.6 | 243.0% | |
| Return on equity | % | 10.5 | 5.6 | 186.0% | |
| Return on capital | % | 19.5 | 4.9 | 395.7% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 356 | 242,192 | 0.1% | |
| From Investments | Rs m | -279 | -85,819 | 0.3% | |
| From Financial Activity | Rs m | -225 | -290,526 | 0.1% | |
| Net Cashflow | Rs m | -148 | -134,152 | 0.1% | |
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.82 Rs / USD
Compare SUVEN LIFE SCIENCES With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare SUVEN LIFE SCIENCES With: CIPLA AJANTA PHARMA SUN PHARMA ALEMBIC PHARMA FDC
Today's Market
Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
Related Views On News
SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)
Aug 28, 2019 | Updated on Aug 28, 2019For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.
SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)
Jul 22, 2019 | Updated on Jul 22, 2019Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.
SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)
May 27, 2019 | Updated on May 27, 2019For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.
More Views on NewsMost Popular
India: Recovery Stalled by Vaccine Games? (The Honest Truth)
Apr 13, 2021Ajit Dayal on how India's vaccine strategy will impact the markets.
4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)
Apr 6, 2021Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
An India Revival Stock I'm Bullish On... (Profit Hunter)
Apr 9, 2021This could take India to the position of 3rd largest economy.
Why Did the Market Crash on Monday? (Fast Profits Daily)
Apr 13, 2021In this video, I'll you what I think is the real reason behind yesterday's market crash.
A Unique Sector for Short-Term Profits (Fast Profits Daily)
Apr 12, 2021This ignored sector could deliver big short-term profits.
More
